Hasil Pencarian - Philipp Ianevski

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma

    High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma oleh Laura Kohtamäki, Mariliina Arjama, Siru Mäkelä, Philipp Ianevski, Katja Välimäki, Susanna Juteau, Suvi Ilmonen, Daniela Ungureanu, Olli Kallioniemi, Astrid Murumägi, Micaela Hernberg

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma

    High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma oleh Katja Tuomainen, Aini Hyytiäinen, Ahmed Al-Samadi, Philipp Ianevski, Aleksandr Ianevski, Swapnil Potdar, Laura Turunen, Jani Saarela, Sergey Kuznetsov, Wafa Wahbi, Maija Risteli, Antti Mäkitie, Outi Monni, Tuula Salo

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity

    Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity oleh Henna Pehkonen, Artemis Filippou, Juho Väänänen, Iida Lindfors, Mira Vänttinen, Philipp Ianevski, Anne Mäkelä, Pauliina Munne, Juha Klefström, Sanna Toppila‐Salmi, Reidar Grénman, Jaana Hagström, Antti A. Mäkitie, Piia‐Riitta Karhemo, Outi Monni

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: